Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1056-1061, May 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mihich, E.
Right arrow Articles by Mulhern, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mihich, E.
Right arrow Articles by Mulhern, A. I.

Toxic and Pathologic Effects of 4,4'-Diacetyl-diphenyl-ureabis(guanylhydrazone), A New Antileukemic Agent1

E. Mihich, C. L. Simpson, L. Loth and A. I. Mulhern

Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14203

The toxic effects of 4,4'-diacetyl-diphenyl-urea-bis(guanyl-hydrazone), a compound with pronounced activity against several mouse leukemias, were studied in mice, rats, rabbits, dogs, and monkeys. In each of these species, i.v. injection of the drug caused acute paralysis leading to apnea and death. In the surviving animals, the acute syndrome was completely reversible within 30 minutes. No cumulative effects occurred in dogs after repeated injection of sublethal paralytic doses. Local cytotoxicity was severe after s.c., i.m., or i.p. doses. Orally, the drug had no effect. Hepatotoxicity occurred in rats, dogs, and monkeys and was the major subacute effect. In these 3 species, acute pulmonary edema and lymphoid depression were also seen. In rats, hypoglycemia occurred terminally after repeated treatments; alopecia and dermatitis also developed. Bone marrow depression was minor.

1 This investigation was supported in part by research Grant CA-04130 from the National Cancer Institute, USPHS.

Received 8/12/68. Accepted 12/20/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.